Insights into epidemiological and clinical burden of bronchiolitis among hospitalized children: a call for preventive interventions - Scorecard - MDSpire
Advertisement
Insights into epidemiological and clinical burden of bronchiolitis among hospitalized children: a call for preventive interventions
Clinical Scorecard: Understanding the Epidemiological and Clinical Impact of Bronchiolitis in Hospitalized Pediatric Patients: Urging for Preventive Strategies
At a Glance
Category
Detail
Condition
Key Mechanisms
Primarily caused by respiratory syncytial virus (RSV), leading to respiratory distress in infants.
Target Population
Care Setting
Key Highlights
Bronchiolitis accounts for 10.4% of pediatric admissions.
Mean age of affected patients is 7.8 months; 59% are male.
RSV identified in 47% of cases.
Median length of stay is 2.7 days with a median cost of 21,776 AED.
Guideline-Based Recommendations
Diagnosis
Use ICD-10 codes J21.0, J21.1, J21.8, J21.9 for bronchiolitis diagnosis.
Management
Supportive care remains the primary management strategy.
Monitoring & Follow-up
Monitor oxygen saturation and respiratory distress levels.
Risks
Younger age, male sex, prematurity, and underlying comorbidities increase risk of severe disease.
Patient & Prescribing Data
Children aged 0–24 months admitted with bronchiolitis.
Management is largely supportive; no effective antiviral therapy currently available.
Clinical Best Practices
Early identification of infants with hypoxia, hypercapnia, or comorbidities is essential.
